A TIMER2 analysis of EIF4A3 expression in tumors and normal tissues indicated that cancer expressed EIF4A3 notably more than normal tissues, such as BLCA, breast cancer, Cholangiocarcinoma, Colon adenocarcinoma, Esophageal carcinoma, etc. compared to the normal tissues. This evidence concerns the gene EIF4A3 and breast cancer.